[go: up one dir, main page]

HU908313D0 - New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives - Google Patents

New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives

Info

Publication number
HU908313D0
HU908313D0 HU908313A HU831390A HU908313D0 HU 908313 D0 HU908313 D0 HU 908313D0 HU 908313 A HU908313 A HU 908313A HU 831390 A HU831390 A HU 831390A HU 908313 D0 HU908313 D0 HU 908313D0
Authority
HU
Hungary
Prior art keywords
2betha
nitro
3betha
tabersonine
betha
Prior art date
Application number
HU908313A
Other languages
Hungarian (hu)
Other versions
HUT59681A (en
HU206883B (en
Inventor
Bela Zsadon
Karolyne Barta
Maria Szilasi
Tibor Keve
Janos Galambos
Kassay Viktoria Bolyane
Balogh Emilia Repasine
Laszlo Szporny
Bela Kiss
Egon Karpati
Eva Palos
Zsolt Szombathelyi
Adam Sarkadi
Aniko Gere
Mihaly Bodo
Katalin Csomor
Judit Laszy
Zsolt Szentirmay
Erzsebet Lapis
Sandor Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to HU908313A priority Critical patent/HU206883B/en
Publication of HU908313D0 publication Critical patent/HU908313D0/en
Priority to IE419891A priority patent/IE914198A1/en
Priority to US07/806,975 priority patent/US5204355A/en
Priority to DE69118340T priority patent/DE69118340T2/en
Priority to ZA919912A priority patent/ZA919912B/en
Priority to PL29281391A priority patent/PL292813A1/en
Priority to KR1019910023172A priority patent/KR920012079A/en
Priority to FI915930A priority patent/FI915930A/en
Priority to EP91311694A priority patent/EP0491549B1/en
Priority to IL100393A priority patent/IL100393A0/en
Priority to CA002057829A priority patent/CA2057829A1/en
Priority to NO91914985A priority patent/NO914985L/en
Priority to AU89725/91A priority patent/AU8972591A/en
Priority to YU195291A priority patent/YU195291A/en
Priority to JP3334992A priority patent/JPH04334380A/en
Priority to CN91107991A priority patent/CN1063690A/en
Publication of HUT59681A publication Critical patent/HUT59681A/en
Publication of HU206883B publication Critical patent/HU206883B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU908313A 1990-12-18 1990-12-18 Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them HU206883B (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
HU908313A HU206883B (en) 1990-12-18 1990-12-18 Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them
IE419891A IE914198A1 (en) 1990-12-18 1991-12-03 NOVEL 15-NITRO-2ß,3ß-DIHYDRO- AND¹15-NITRO-2ß,3ß,6,7-TETRAHYDROTABERSONINE DERIVATIVES,¹PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR¹PREPARING SAME
US07/806,975 US5204355A (en) 1990-12-18 1991-12-12 15-nitro-2β, 3β-dihydro- and 15-nitro-2β,3β,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
AU89725/91A AU8972591A (en) 1990-12-18 1991-12-17 Novel 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
EP91311694A EP0491549B1 (en) 1990-12-18 1991-12-17 Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
CA002057829A CA2057829A1 (en) 1990-12-18 1991-12-17 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydro tabersonine derivatives, pharmaceutical compositions containing them andprocess for preparing same
PL29281391A PL292813A1 (en) 1990-12-18 1991-12-17 Method of obtaining novel derivatives of 15-nitro-2Ÿ, 3Ÿ, 6,7-tetrahydrotabersonine
KR1019910023172A KR920012079A (en) 1990-12-18 1991-12-17 15-nitro-2β, 3β-dihydro- and 15-nitro 2β, 3β, 6, 7-tetrahydrotaversonine derivatives, pharmaceutical compositions comprising them and methods for their preparation
FI915930A FI915930A (en) 1990-12-18 1991-12-17 NYA 15-NITRO-2B, 3B-DIHYDRO- OCH 15-NITRO-2B, 3B, 6,7-TETRAHYDROTABERSONINDERIVATER, PHARMACEUTICAL SAMMANSAETTNINGAR INNEHAOLLANDE DEM OCH DERAS FRAMSTAELLNINGSMETOD.
DE69118340T DE69118340T2 (en) 1990-12-18 1991-12-17 New 15-nitro-2-beta, 3 beta-dihydro and 15-nitro-2-beta, 3-beta, 6,7-tetrahydrotabersonine derivatives, medicaments containing them and process for their preparation
IL100393A IL100393A0 (en) 1990-12-18 1991-12-17 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,their preparation and pharmaceutical compositions containing them
ZA919912A ZA919912B (en) 1990-12-18 1991-12-17 Novel 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,pharmaceutical compositions containing them and process for preparing same
NO91914985A NO914985L (en) 1990-12-18 1991-12-17 PROCEDURE FOR THE PREPARATION OF 15-NITRO-TABERSONIN DERIVATIVES
CN91107991A CN1063690A (en) 1990-12-18 1991-12-18 New tabersonine derivative contains pharmaceutical composition of this compounds and preparation method thereof
YU195291A YU195291A (en) 1990-12-18 1991-12-18 NEW 15-NITRO-2BETA, 3BETA-DIHYDRO AND 15-NITRO-2-BETA, 3BETA, 6,7-TETRAHYDROTABERSONINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE PROCEDURE FOR OBTAINING THEM
JP3334992A JPH04334380A (en) 1990-12-18 1991-12-18 New 15-nitro-2beta, 3beta-dihydro-and 15-nitro-2beta, 3beta,6,7-tetrahydrotabersonine derivative, drug composition containing same, and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU908313A HU206883B (en) 1990-12-18 1990-12-18 Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
HU908313D0 true HU908313D0 (en) 1991-07-29
HUT59681A HUT59681A (en) 1992-06-29
HU206883B HU206883B (en) 1993-01-28

Family

ID=10972531

Family Applications (1)

Application Number Title Priority Date Filing Date
HU908313A HU206883B (en) 1990-12-18 1990-12-18 Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5204355A (en)
EP (1) EP0491549B1 (en)
JP (1) JPH04334380A (en)
KR (1) KR920012079A (en)
CN (1) CN1063690A (en)
AU (1) AU8972591A (en)
CA (1) CA2057829A1 (en)
DE (1) DE69118340T2 (en)
FI (1) FI915930A (en)
HU (1) HU206883B (en)
IE (1) IE914198A1 (en)
IL (1) IL100393A0 (en)
NO (1) NO914985L (en)
PL (1) PL292813A1 (en)
YU (1) YU195291A (en)
ZA (1) ZA919912B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
CN102558178B (en) * 2012-01-09 2015-06-03 中国科学院昆明植物研究所 Tabersonine derivative, pharmaceutical compositions, preparing method and medical application thereof
CN106061984A (en) 2014-02-13 2016-10-26 配体药物公司 Prodrug compounds and their uses
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
JP2021509907A (en) 2018-01-09 2021-04-08 リガンド・ファーマシューティカルズ・インコーポレイテッド Acetal compounds and their therapeutic use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358147A1 (en) * 1976-07-13 1978-02-10 Parcor ASPIDOSPERMIDINS
JPS62234054A (en) * 1985-12-16 1987-10-14 Ono Pharmaceut Co Ltd 3-phenoxy(or phenylthio)cyclopentanecarbonylamino acid derivative and remedy for cerebral edema containing said derivative as active ingredient

Also Published As

Publication number Publication date
EP0491549B1 (en) 1996-03-27
NO914985L (en) 1992-06-19
CN1063690A (en) 1992-08-19
JPH04334380A (en) 1992-11-20
DE69118340T2 (en) 1996-08-29
HUT59681A (en) 1992-06-29
FI915930A (en) 1992-06-19
ZA919912B (en) 1992-10-28
CA2057829A1 (en) 1992-06-19
IL100393A0 (en) 1992-09-06
IE914198A1 (en) 1992-07-01
AU8972591A (en) 1992-06-25
KR920012079A (en) 1992-07-25
DE69118340D1 (en) 1996-05-02
EP0491549A1 (en) 1992-06-24
NO914985D0 (en) 1991-12-17
YU195291A (en) 1994-04-05
FI915930A0 (en) 1991-12-17
HU206883B (en) 1993-01-28
PL292813A1 (en) 1992-12-14
US5204355A (en) 1993-04-20

Similar Documents

Publication Publication Date Title
ZA914194B (en) 1,4-diamino-2,3-dihydroxybutanes
HU912356D0 (en) Rapacmycine derivatives
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
ZA916098B (en) Oxazolidinodione derivatives
ZA919660B (en) Alpha-oxoacetamide derivatives.
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
ZA9172B (en) Azaoxindole derivatives
PH30977A (en) Hiv-inhibiting benzene-acetamide derivatives.
ZA916058B (en) Novel 1,4-dihydropyridine derivatives
GB2260135B (en) Substituted 2,6-diaminotoluenes
HU9302314D0 (en) 1,4-benzodioxane derivatives
EP0481950A3 (en) 1,4-dideoxy-4-fluoronojirimycin
EP0482206A4 (en) 4,6-o-hydroxyphosphorylglucosamine derivative
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
EP0440949A3 (en) Halogenallyl-azolyl derivatives
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
ZA90301B (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
AP9100308A0 (en) Carboxymethylcyclopropane derivatives
ZA925184B (en) 3,4-dehydropiperidine derivatives
IE901509L (en) 1,5-benzothiazepin derivatives
IE900167L (en) 8,9-ANNELATED-1,2,3,4-TETRAHYDRO-ß-CARBOLINE DERIVATIVES
EP0444276A3 (en) 1,2,4-triazolyl-propanol derivatives
HU9402902D0 (en) 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives
EP0449346A3 (en) 4-piperidinyl-ergoline derivatives
IE902043L (en) 2,5-diaryltetrahydrofurans

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee